The expression of various components of the antigen receptor is closely associated with the developmental progression of B lymphocytes. For this reason, introduction of rearranged Ig transgenes exerts profound effects on B cell development. In these studies we show that the presence of transgenes for both µ and δ H as well as L chains accelerates the rate of B cell maturation resulting in the appearance of large numbers of IgD-expressing B lymphocytes in vitro that are otherwise undetectable. In addition, allelic exclusion, normally exerted very effectively by these particular transgenes (carried in the MD-3 strain), was lost in the long-term bone marrow cultures. These findings can be recapitulated in vivo by serial adoptive transfers of bone marrow cells from the transgenic animals into lethally irradiated recipients. We conclude from these studies that allelic exclusion is not necessarily mediated by any one event but may be a result of the integrated occurrence of Ig H chain gene rearrangement, accumulation of transcription factors, along with the ordered progression of B cell differentiation under the influence of the appropriate inductive microenvironment. These findings may account for at least some of the observed cases of allelic inclusion in transgenic animals.
Introduction
During early development B lymphocytes progress through a series of distinct stages that has been well characterized in terms of surface markers (1) (2) (3) , rearrangement status of the Ig H and L chain genes (4, 5) as well as acquisition of functional capabilities (6, 7) . Developmental progression through these stages is regulated by the timely activation of specific transcription factors mediated by the stromal microenvironment and/or appropriate growth factors (6, 7) . The activities of these specific transcription factors initiate expression of a number of genes found to be necessary for this progression including, for example, expression of Igα and Igβ and of the surrogate L chains, as well as DJ and VDJ rearrangement, and activation of the L chain locus (7) (8) (9) (10) (11) (12) (13) (14) . Studies of mutant mice with various disrupted genes have provided convincing evidence that the Ig H chain protein together with surrogate L chain is necessary for progression of B lymphocyte development beyond the pro-B stage (15) (16) (17) . In addition, studies of B cell development in transgenic mice expressing a rearranged µ chain gene or L chain gene suggests that transgene expression regulates B cell development by driving differentiation towards the next stage and depleting cells residing in the preceding stage (18, 19) . If the presence of a µ transgene increases the rate of progression of B cell development one would expect that in transgenic animals carrying both rearranged H and L chain genes, as in the MD-3 strain (20) , the acquisition of cell surface IgD would be also accelerated. However, it is interesting that in these animals there is little expression of IgD in the bone marrow with the exception of mature, B220 hi , cells that are likely to be derived from recirculating mature B cells from the periphery (21) . Thus, it is not clear whether the bone marrow environment is inadequate for induction of IgD expression or cells emigrate from the bone marrow as soon as they acquire IgD.
To resolve this question we prepared long-term bone marrow cultures (LTBMC) from the MD-3 strain. We found that in these cultures transgene expression does occur at a much earlier stage of B cell development resulting in the expression of IgM and IgD on B220 ϩ cells which still express CD43 ϩ . Surprisingly, we also found allelic inclusion in the cultures. The expression of a complete µ chain is believed to be important for regulation of allelic exclusion (21) . A truncated µ chain derived from DJ rearrangements in the correct reading frame (23) together with the surrogate L chain (24) may also be necessary for prevention of further rearrangement of the allelic chromosome. Consistent with this hypothesis is the documentation of complete inhibition of endogenous gene rearrangement by the integration of a functional µ transgene (25, 26) presumably because the transgene can be expressed at a very early stage of B cell differentiation. In fact, in the earliest documented B cell precursor stage, a µ transgene is already expressed at a time prior to appreciable expression of the RAG genes (27) . However, analysis of a number of strains bearing rearranged µ transgenes has indicated that this earlier expression of the transgene does not necessarily block endogenous gene rearrangement. In some cases both endogenous and transgene expression can be detected on the same cell (28) . More frequently, the loss of allelic exclusion is exhibited at the level of the total population in that individual cells express either the endogenous gene or the transgene but not both (reviewed in 29 and 30). Furthermore, 'knock-in' mutants in which a rearranged gene has been targeted into the Ig H chain locus contain cells that express the endogenous genes (31); however, in this case also, allelic exclusion is operative at the cellular level in these animals in that each cell does not express more than one allotype.
In order to determine if our in vitro findings can be detected in vivo we performed serial transfers of B cell progenitors into lethally irradiated hosts and monitored the generation of new B lymphocytes. These experiments show that animals transferred with MD-3 donors generate mature B lymphocytes at a more rapid rate than those transferred with control cells. Furthermore, under conditions of serial transfer which deplete B cell precursors, allelic exclusion is not complete. Surprisingly, some cells expressing only endogenous genes can be shown to still contain the transgenic H chain gene even though it is not expressed. These experiments reveal a level of regulation after V(D)J recombination that may be related to the appropriate induction of critical transcription factors at defined stages of B cell development.
Methods

Animals
FVB/N mice were purchased from the Jackson Laboratory (Bar Harbor, ME). The MD-3 transgenic mouse line carrying a rearranged Ig H chain gene with µ and δ encoding regions in the genomic context (MD-3) (20) was obtained from Dr Christopher Goodnow (Howard Hughes Medical Institute, Stanford Medical Center, Stanford, CA) and maintained in our facilities. Mice carrying the transgene were typed by FACS staining with δ b and µ a reagents as described below. The 992 transgenic strain also carries µ and δ encoding regions but has a deletion in the intronic region between the two genes. The line does not express transgenic IgM but expresses transgenic IgD on all B lymphocytes (32) . The RAG-2-/-strain (33) maintained on the FVB/N background was kindly provided by Dr Mark Siegelman (UT Southwestern Medical Center, Dallas, TX).
Irradiation and reconstitution
Recipient C57BL/6, FVB/N and RAG-2-/-mice were exposed to 750 rad 137 Cs γ irradiation (Gamma Cell 40; Atomic Energy, Ottawa, Ontario, Canada). Within 6 h the animals were injected with bone marrow cells resuspended in at least 0.5 ml of sterile PBS. Animals were kept in microisolator cages until sacrificed.
Cell preparation
Red blood cells in tail vein bleeds were lysed to prepare peripheral blood lymphocytes. Spleen and bone marrow cells were prepared as previously described (34) . Establishment of LTBMC of bone marrow cells from control and transgenic animals followed procedures modified from Whitlock and Witte (35) as described previously (34) . For FACS analysis of LTBMC B lymphocytes, loosely adherent lymphocytes were removed by agitation from the cultures.
Flow cytometric analysis
Peripheral blood lymphocytes, spleen or bone marrow cells were washed once in PBS containing 1% BSA and 2% dried milk protein, and twice in PBS containing 1% BSA. Then, 5ϫ10 5 cell aliquots were stained with pre-determined optimal dilutions of each antibody in 20 µl aliquots of 1% BSA containing 0.02% NaN 3 . FITC-anti-IgD a (AMS9.1), biotin-labeled anti-IgD b (217-170), FITC-anti-IgM a (DS-1), biotin-labeled anti-B220 (RA3-6B2) and FITC-anti-CD43 (S7) mAb were purchased from PharMingen (San Diego, CA). Goat anti-IgM (Jackson Immunoresearch, Westgrove, PA) was coupled to biotin according to methods described by Goding (36) . Biotinlabeled antibodies were visualized by streptavidin-Red670. Mouse anti-H2 q (37) was obtained from Dr James Forman (UT Southwestern Medical Center, Dallas, TX). Binding was detected by FITC-goat anti-mouse IgG F(abЈ) 2 (Jackson Immunoresearch). This secondary antibody alone stained Ͻ1% of B lymphocytes. Phycoerythrin-conjugated anti-CD23 (B3B4; 38) was a kind gift from Dr Tom Waldsmichmidt (University of Iowa College of Medicine, Iowa City, IA). Stained cells were analyzed on the FACScan flow cytometer (Becton-Dickinson, San Jose, CA). Except for early times (before day 8) after irradiation no autoflorescence was detected on unstained cells. In addition, all the reagents used did not exhibit FcR binding and inclusion of anti-FcRII antibodies (24G2) did not alter staining profiles (data not shown).
PCR and RT-PCR analysis of splenic RNA
DNA was extracted from cell pellets by incubating with proteinase K (1.2 mg/ml) in Tris-NaCl buffer overnight at 55°C followed by phenol-chloroform extraction and ethanol precipitation.
RNA was prepared by extraction in the presence of guanidinium thiocyanate as previously described (39) . Total RNA was primed with oligo(dT) 15 Primer (Promega, Madison, WI) and reverse transcribed with M-MLV RT (Gibco/BRL, Gaithersburg, MD). RT-PCR was carried out with an oligonucleotide specific for the VDJ H 3 junction of the HyHEL-10 H chain gene (40) used to generate the transgenic MD-3 line (5Ј-GCAAACTGGGACGGTGATTA) together with a C µ 1-specific primer (5Ј-TAGGTACTTGCCCCCTGTCCT). RNA derived from the HyHel-10 H chain gene should yield a RT-PCR product of 250 bp. For amplification of DNA sequences the same 5Ј primer was used together with a J H 4 primer (5Ј-CCTGAGGAGACGGTGA). The MD-3 gene rearrangement yields a product of 785 bp.
Counter-current elutriation
Counter-current elutriation was performed using a Beckman J-6M centrifuge with a JE-5.0 rotor and a standard chamber (Beckman Instruments, Palo Alto, CA) using methods modified from that described by Jones et al. (41) . Cells were loaded at a flow rate of 15 ml/ml and a rotor speed of 3000 r.p.m. Four fractions were eluted by increasing the flow rate to 28, 33, 36 and 67 ml/min respectively.
Magnetic cell separation
To isolate IgM bϩ cells, spleen cells were incubated with FITCanti-µ b at 15 µl/10 8 cells. After washing 15 µl of anti-FITC magnetic beads (Miltenyl Biotec, Auburn, CA) was added and after further washing the cells was passed through a MACS separation column according to the manufacturer's instructions. The adherent cells were recovered and passed through a second column, analyzed by flow cytometry, and processed for RNA and DNA.
Results
Transgene expression in LTBMC
In order to determine if the presence of transgenes affects the rate of development of early B lymphocytes from B cell precursors we prepared LTBMC from the MD-3 strain and compared their development with LTBMC from C57BL/6 mice. The MD-3 strain carries both H and L chain transgenes that together results in the expression of surface Ig with specificity for hen egg lysozyme (20) . Easy distinction of transgene expression from the endogenous gene can be made because the a allotype is encoded by the H chain transgene. In virtually all animals of this line tested the presence of the transgene exerts strong allelic exclusion in that the endogenous Ig genes are not detectably expressed (see, e.g. Figs 6 and 7, donor FACS profiles). To assess the rate of development of mature B lymphocytes, lightly adherent lymphocytes were harvested from the LTBMC at 3 weeks after initiation of culture as soon as sufficient numbers of newly emergent small lymphocytes could be analyzed. Figure 1 shows that the majority of cells falling in the small cell gate expressed B220 in both types of cultures examined. However, a dramatically higher proportion of the B220 ϩ cells in the cultures from MD-3 animals already expressed surface IgM. Further analysis of the cultures from MD-3 animals showed that virtually all of the small lymphocytes derived from 3 week cultures still bore CD43, indicating that they are relatively immature ( Fig. 2A) and therefore unlikely to be mature B cells that have survived the culture period. Furthermore, only a small portion of the IgM ϩ cells co-expressed transgenic IgD (Fig. 2B ) and, at low intensity, a phenotype similar to neonatal B lymphocytes (42) . By 5 weeks of culture, however, CD43 was lost from the majority of the small lymphocytes and~50% of the IgM ϩ cells now expressed IgD (Fig. 2D) . In contrast, the maximum number of IgM ϩ cells appearing in cultures of C57/BL6 animals never exceeded 20% and cell surface IgD was seldom expressed at detectable levels as exemplified by the FACS analysis shown on Fig. 2(F and G) .
In addition to the transgene, late in culture MD-3 cultures began to also express the endogenous gene (Fig. 2C) such that many cells expressed both transgenic IgM (a allotype) and endogenous IgD (b allotype). However, very few doubleexpressing cells bearing IgM of both allotypes were found, although in some cultures the cells bore predominantly only the endogenous allotype (data not shown). These data suggest that double expression of dual IgD allotypes is more permissible than double expression of IgM allotypes.
Significantly, there was a rapid decline in the number of small lymphocytes in the MD-3 cultures which was not apparent in the control cultures as shown by the comparison of the kinetics of appearance of IgM-expressing B lymphocytes in a representative culture from each strain (Fig. 3) . Furthermore, whereas new waves of small lymphocytes continued to emerge from LTBMC of normal mice for sometimes up to 3 months of culture, cultures of MD-3 mice ceased to generate new lymphocytes.
These experiments show that previously rearranged H and L chain transgenes are expressed at much earlier stages on immature B lymphocytes. Furthermore, the expression of IgD indicates that the bone marrow environment can adequately provide signals for the initiation of δ gene transcription. The rapid expression of surface Ig appears to deplete the bone marrow cultures of precursors that can continue to give rise to new B cells in control culture for extended periods. In contrast to these findings from LTBMC, immature IgD ϩ (CD43 ϩ , B220 lo ) cells were not observed in the bone marrow of intact animals and the number of B220 ϩ cells was not significantly lower. However, these are steady-state conditions; therefore, in order to follow the development of newly emergent B cells, bone marrow precursors were transferred into lethally irradiated animals. 
B precursors from MD-3 mice mature more rapidly in reconstituted animals
As shown in Fig. 4 , bone marrow cells usually contain a low number of recirculating mature lymphocytes as indicated by the higher intensity of B220 staining on IgD ϩ cells. In order to transfer only immature B cells, bone marrow cells were fractionated by counter-current elutriation. Using this separation procedure fractions can be collected that progressively increase in size (e.g. compare Fractions I and IV, top panels) and contain decreasing numbers of small lymphocytes. Thus Fraction I is enriched for the recirculating mature B cells, whereas Fraction IV contains cells that are not only depleted of Ig-expressing cells but also express only low levels of B220. These cells were transferred into lethally irradiated, syngeneic hosts (C57BL/6). As controls bone marrow cells prepared in the same manner from another transgenic strain were transferred. The 992 strain carries only a H chain transgene containing sequences for both µ and δ H chains. However, presumably because of an intragenic deletion between the two genes the animals do not express IgM carrying the transgenic µ chain but the transgenic δ chain is expressed on all mature cells. Because of the absence of transgenic µ chain expression rearrangement of the endogenous H chain genes is not inhibited and developmental progression is not dissimilar from control animals (32) . The H chain transgene also bears the a allotype and provides a convenient marker for donor B cells when transferred into syngeneic C57BL/6 hosts. Figure 5 shows that as early as 5 days after transfer small numbers of B220 ϩ cells expressing transgenic IgD lymphocytes can be detected in the spleen of animals reconstituted with MD-3 cells. In contrast, neither IgD nor IgM can be detected on splenocytes from animals reconstituted with cells from 992 animals. By day 15, low numbers of IgD ϩ cells can be detected in the spleens of animals transferred with 992 cells; however, the percentage is still far below that of animals transferred with MD-3 donor cells. It is not until day 23 that similar percentages were achieved in animals reconstituted with the two different strains. It should be noted that the difference in intensity of IgD expression in animals transferred with MD-3 versus 992 cells is identical to their expression in non-manipulated animals (32).
Precursor depletion results in loss of allelic exclusion in secondary recipients
The analysis of LTBMC of cells from the MD-3 strain indicated that the rapid development of mature B lymphocytes is accompanied by a depletion of immediate B cell precursors (Fig. 3) . To test if this is occurring in vivo 20 days after reconstitution, bone marrow cells from the first recipients were transferred into another series of lethally irradiated syngeneic animals to test their capacity to regenerate new B cells. Control transfers were also made from primary recipients reconstituted with C57BL/6 cells.
Interestingly, after this secondary transfer analysis of the recipient spleens at day 28 showed that there was a distinct population of IgM ϩ cells that did not carry the a allotype although the transgene expression still predominated (Fig. 6) . In order to address the first possibility, we used irradiated FVB/N mice instead of C57BL/6 mice as the final recipient (Fig. 6 ). In this recipient IgM bϩ cells were also detected in the spleen 4 weeks after transfer. Cells bearing the b allotype could not be derived from the recipient because the FVB/N strain carries the Igh-C a haplotype. Furthermore, all of the IgD aϩ cells in the spleen were derived from the donor bearing the transgene because none of them co-express H-2 q , the recipient H-2 type. In fact very few B220 ϩ H-2 q -expressing cells could be detected in the bone marrow (data not shown). Thus, this allogeneic transfer experiment, in which no rescue of host cells could be observed within this time period, provides good evidence that in the case of syngeneic transfer few Ig b allotype-bearing cells could have been derived from the host since the likelihood of rejection should be lower.
In order to address the second possibility that the Ig b cells could be derived from the intermediate recipient, we used for intermediate recipients irradiated RAG-2-/-FVB/N animals and C57BL/6 animals as final hosts. In this case precursor cells derived from the intermediate recipient could not give rise to any Ig-bearing cells because of the deficiency in RAG-2 gene expression. Indeed, FACS staining of spleen and bone marrow cells from these animals at 4 weeks after transfer revealed no H-2 qϩ B cells (data not shown). Bone marrow cells from these intermediate hosts were transferred into lethally irradiated C57BL/6 recipients. Analysis of these final hosts (Fig. 7) showed considerable heterogeneity in expression between different animals even though approximately equal numbers of donor cells were injected. Some animals showed ample transgene expression (Fig. 7) ; however, interestingly, all of the transgene-expressing cells expressed, in addition, IgD bearing the b allotype. Thus every spleen cell in these animals expressed the endogenous gene as well as the transgenes indicating a complete failure of allelic exclusion. Significantly, these cells did not express endogenous IgM (IgM b ). Other animals, on the other hand, contained a distinct population of cells in both the bone marrow and periphery that did not express transgenic IgM at all. Because few of these cells could be derived from the intermediate or the final host, they must be from the original donor.
In order to further ascertain that cells bearing the b allotype can indeed be derived from the original donor, we isolated spleen cells bearing the endogenous allotype by surface staining and positive magnetic bead selection. After a double pass Ͼ97% of the population expressed the b allotype and did not contain cells bearing the a allotype. The absence of transgene expression was confirmed by RT-PCR analysis (Fig. 8) showing that a primer specific for the transgene failed to amplify the appropriate 250 bp band from the MD-3 H chain. Interestingly the multiple bands of other sizes amplified from RNA of control C57BL/6 spleen cells were also absent in the selected cells, suggesting a more limited endogenous gene repertoire. Amplification of genomic DNA from the same populations (Fig. 8) showed, however, that the transgene is present, albeit at lower levels, despite the lack of expression. Thus, under these conditions of multiple transfers, which effectively depletes precursors from the original donor, a population of cells can be revealed that no longer has the developmental advantage of a pre-rearranged transgene. However, because of the lower level of amplification from the transgene we cannot rule out some contribution from the final host in this animal. This possibility is also suggested by the presence of two distinct populations of IgM b -expressing cells that was not present in other animals transferred in the same manner (data not shown).
Discussion
The major conclusion derived from the experiments presented above is that the presence of transgenic H and L chain genes exerts significant effects on the growth and differentiation of B lymphocytes. First, we have shown that B cell development is accelerated. In vitro it is manifested in the appearance of surface Ig at an early B cell differentiation stage when surface Ig cannot be expressed because the L chain gene has not yet rearranged. A similar phenotype, represented by Ig ϩ , B220 ϩ CD43 ϩ cells, was not detected in vivo (data not shown), presumably because these cells rapidly differentiate to the next stage and the population is too small to be easily detectable. However, the detection of Ig ϩ cells in the spleen of lethally irradiated mice reconstituted with MD-3 precursor cells as early as 5 days post-transfer provides some in vivo evidence for accelerated development. Similar transfer experiments performed with wild-type animals (43) and confirmed recently (44) showed that IgD ϩ cells cannot be detected in the spleen of hosts until at least 12 days post-transfer.
The rapid B cell differentiation induced by the presence of the transgenes allows the accumulation of mature B cells expressing both IgM and IgD in LTBMC. In contrast, IgM ϩ IgD ϩ cells that are not derived from the recirculating peripheral pool are not readily detectable in the bone marrow of either transgenic or wild-type mice. We have previously shown that IgD expression requires both regulatory factors that can at least partially alleviate the transcriptional termination occuring between the µ and δ genes as well as additional factors that allow splicing to occur from the VDJ segment to the C δ exons (32) . The results presented herewith indicate that the bone marrow environment is clearly not deficient in inductive factors that can provide signals leading to both of these events resulting in the accumulation of mature cells in vitro. However, we have noted that after acquisition of IgD, cells in the MD-3 cultures die very rapidly suggesting an absence of signals necessary for maintenance of mature B cells. Thus the absence of mature B cells expressing IgD in most LTBMC of non-transgenic animals must be due to the slower and less synchronous rate of development. Furthermore, if IgD can be induced in the bone marrow the paucity of these cells in vivo must be attributed their rapid emigration to the periphery as soon as IgD is acquired. It remains to be determined whether the rapid exodus requires IgD per se or other maturational events. In this regard it is interesting that irradiation and reconstitution experiments using subpopulations marked by J11D expression have led to the conclusion that high-level IgD expression may be acquired only after B cells exit the bone marrow where peripheral influences can further impact B cell development (44) .
In cultures of normal mice, B cell development occurs in successive waves and new cells can be produced over a period of 2-3 months (35) . In contrast, LTBMC from MD-3 mice are limited in growth potential. The initial absence of new growth can be accounted for by rapid differentiation that depleted the immediate precursors. However, the absence of further appearance of clones from earlier precursors suggests that these precursors are already decreased in the original explant. The decrease is not evident in vivo, however, because even upon the first transfer, significant differences were not detected between MD-3 versus control animals. On the other hand, upon second transfer, allelic exclusion, that is complete in both the first and second donors, is imperfect, suggesting that precursors that can mature rapidly are relatively decreased. Thus some animals can now express the endogenous H chain gene, either together with the transgene on the same cell or on a distinct population that does not express the transgene at all. We have shown that few of these cells are derived from either the intermediate or the final hosts but indeed continue to carry the transgenic H chain gene even when it is not expressed. The L chain gene expression was not investigated but because of the pre-rearranged status it is likely that the endogenous gene is associated with transgenic L chains accounting perhaps for the decreased heterogeneity noted in cDNA of the IgM bϩ cells. Unlike other µ transgenic animals that exhibit incomplete allelic exclusion (45), endogenous gene expression was not observed even after primary transfers from these cells (see Fig. 6 ). Therefore the occurrence of endogenous gene rearrangement in the secondary transfers cannot be due to some attribute of this particular transgenic strain such as chromosomal integration site (46) , copy number or V region specificity (reviewed in 29). It is also unlikely that the double isotype expression can be attributed to anti-idiotypic reactivity of the transgenic antibodies (47) or antigenic selection by the sojourn in the allogeneic host (FVB/N) because such double expressers were not detected until the second transfer. In addition, the endogenous gene arrangement is not restricted to a subpopulation of B cells such as that belonging to the B1 subset (28) since we have found that all of the IgD a IgD b double-expressing cells also express CD23 (data not shown), a marker specific for B2 cells (48) . Thus, the deregulated expression appears to result from these particular transfer conditions which permitted the emergence of cells in which transgene expression has apparently lagged behind rearrangement of the endogenous gene. The ineffective or delayed transcription of the transgene in the precursors of these cells could be attributed to a deficiency in the full assembly of transcription factors necessary for initiation of µ gene transcription. It is relevant in this regard to consider the recent observation that introduction of rearranged H and L chain transgenes does not reconstitute B cell development in mice deficient in E47 (10), suggesting that without appropriate transcription factors even rearranged genes cannot be transcribed. It is possible that the alterations in differentiation kinetics induced by the transgenes caused an imbalance between specific cell subpopulations that have arrived at a particular differentiative stage versus the appropriate environmental factors that can induce the full complement of transcription factors necessary for differentiation to the next stage. This hypothesis provides one reason for the variable degree of endogenous gene rearrangement found in some strains of µ transgenic mice. Alternatively, these observations made with the MD-3 strain may not be an artifact of having introduced a transgene but may actually be indicative of a stage of B cell development that is relatively transient and not readily detectable under steady-state conditions. However, it may be possible to obtain evidence for such a stage by examining B lymphocytes from wild-type heterozygous animals after serial Fig. 6 except that both the first and second transfers were performed at 4 weeks. Spleen cells from individual final recipients were then stained with FITC-anti-IgM b and positively selected by MACS separation as described in Methods. The selected cells were restained and nucleic acids extracted. Equal cell equivalents from the adherent and non-adherent fractions were subjected to RT-PCR and PCR using a 5Ј oligonucleotide specific for the VDJ junction of the HyHEL-10 H chain gene and either C µ 1 or J H 4 3Ј oligonucleotides respectively. The ethidium bromide stain of the PCR products is presented.
transfer or in animals with mutations of growth factor genes. Thus, although we have performed control experiments using non-transgenic animals they were all syngeneic transfers.
The documentation of B lymphocytes expressing more than one antigen receptor is not unprecedented (14, 28) . However, Imanishi-Kari et al. have shown that in mature B cells either the transgene or the endogenous gene is usually downregulated (30) . It is interesting that serial transfer of MD-3 cells resulted in double expression of both alleles of only IgD but not IgM. On the other hand, in animals, as well as LTBMC where endogenous IgM-expressing cells were found, the transgene expression is suppressed, resulting in expression of only one allotype. It would be of interest to determine whether this reflects more effective selection mediated by IgM rather than IgD receptor or is a consequence of 'H chain toxicity' (49) operating only on µ chains. It should be noted that although such selection is absent in the double 'knockin' mutants expressing two different IgM receptors (50) , the limited repertoire may have restricted the process.
In conclusion, in these experiments utilizing a well-established transgenic cell line that displays very little violation of the allelic exclusion rule under steady-state conditions, we have shown that the expression of the transgene can nevertheless be altered depending on the developmental conditions. Thus it is possible that allelic inclusion is not observed during normal B cell development because Ig H chain gene rearrangement is so intimately associated with progression of B cell differentiation, two processes that are closely associated yet separable (51) and both regulated by assembly of specific transcription factors that are in turn regulated by the appropriate environmental stimuli.
